Company registration number 03075360 (England and Wales)
MEDIMOTION LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
PAGES FOR FILING WITH REGISTRAR
MEDIMOTION LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
MEDIMOTION LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2025
31 October 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
5
509,283
576,488
Investments
6
100
100
509,383
576,588
Current assets
Stocks
222,867
229,522
Debtors
8
1,345,242
1,197,853
Investments
9
1,709,855
1,973,361
Cash at bank and in hand
1,410,937
854,571
4,688,901
4,255,307
Creditors: amounts falling due within one year
10
(364,013)
(315,355)
Net current assets
4,324,888
3,939,952
Total assets less current liabilities
4,834,271
4,516,540
Provisions for liabilities
(127,257)
(144,001)
Net assets
4,707,014
4,372,539
Capital and reserves
Called up share capital
2
2
Capital redemption reserve
1
1
Profit and loss reserves
4,707,011
4,372,536
Total equity
4,707,014
4,372,539
MEDIMOTION LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 OCTOBER 2025
31 October 2025
- 2 -

For the financial year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 22 May 2026 and are signed on its behalf by:
Mr G R Martin
Director
Company registration number 03075360 (England and Wales)
MEDIMOTION LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
- 3 -
1
Accounting policies
Company information

Medimotion Limited is a private company limited by shares incorporated in England and Wales. The registered office is Gwastod Abbot, New Inn, Pencader, Dyfed, United Kingdom, SA39 9AZ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery
25% reducing balance
Fixtures, fittings & equipment
25% reducing balance
Computer equipment
33.3% straight line
Motor vehicles
20% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

MEDIMOTION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
- 4 -

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

MEDIMOTION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
- 5 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.8
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.9
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was -

2025
2024
Number
Number
Total
3
4
4
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
103,178
66,851
Adjustments in respect of prior periods
(194)
(275)
Total current tax
102,984
66,576
MEDIMOTION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
4
Taxation
2025
2024
£
£
(Continued)
- 6 -
Deferred tax
Origination and reversal of timing differences
(16,744)
20,425
Total tax charge
86,240
87,001
5
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 November 2024
799,008
Additions
480,845
Disposals
(589,991)
At 31 October 2025
689,862
Depreciation and impairment
At 1 November 2024
222,520
Depreciation charged in the year
90,239
Eliminated in respect of disposals
(132,180)
At 31 October 2025
180,579
Carrying amount
At 31 October 2025
509,283
At 31 October 2024
576,488
6
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
100
100
7
Subsidiaries

Details of the company's subsidiaries at 31 October 2025 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Cadence West Investments Limited
England & Wales
Ordinary
100.00
MEDIMOTION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 7 -
8
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
162,502
95,056
Amounts owed by group undertakings
1,102,359
1,101,009
Other debtors
80,381
1,788
1,345,242
1,197,853
9
Current asset investments
2025
2024
£
£
Other investments
1,709,855
1,973,361
10
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
2,391
9,426
Corporation tax
103,178
66,851
Other taxation and social security
31,590
17,560
Other creditors
226,854
221,518
364,013
315,355

On 12 January 2021, Barclays Bank Plc secured a fixed and floating charge over the company and all property and assets, present and future.

2025-10-31 2024-11-01 false false false 22 May 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mr G R Martin Mrs G M Martin 03075360 2024-11-01 2025-10-31 03075360 2025-10-31 03075360 2024-10-31 03075360 core:OtherPropertyPlantEquipment 2025-10-31 03075360 core:OtherPropertyPlantEquipment 2024-10-31 03075360 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 03075360 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 03075360 core:WithinOneYear 2025-10-31 03075360 core:WithinOneYear 2024-10-31 03075360 core:CurrentFinancialInstruments 2025-10-31 03075360 core:CurrentFinancialInstruments 2024-10-31 03075360 core:ShareCapital 2025-10-31 03075360 core:ShareCapital 2024-10-31 03075360 core:CapitalRedemptionReserve 2025-10-31 03075360 core:CapitalRedemptionReserve 2024-10-31 03075360 core:RetainedEarningsAccumulatedLosses 2025-10-31 03075360 core:RetainedEarningsAccumulatedLosses 2024-10-31 03075360 bus:Director1 2024-11-01 2025-10-31 03075360 core:PlantMachinery 2024-11-01 2025-10-31 03075360 core:FurnitureFittings 2024-11-01 2025-10-31 03075360 core:ComputerEquipment 2024-11-01 2025-10-31 03075360 core:MotorVehicles 2024-11-01 2025-10-31 03075360 2023-11-01 2024-10-31 03075360 core:UKTax 2024-11-01 2025-10-31 03075360 core:UKTax 2023-11-01 2024-10-31 03075360 core:OtherPropertyPlantEquipment 2024-10-31 03075360 core:OtherPropertyPlantEquipment 2024-11-01 2025-10-31 03075360 core:Subsidiary1 2024-11-01 2025-10-31 03075360 core:Subsidiary1 1 2024-11-01 2025-10-31 03075360 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 03075360 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 03075360 bus:FRS102 2024-11-01 2025-10-31 03075360 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 03075360 bus:Director2 2024-11-01 2025-10-31 03075360 bus:FullAccounts 2024-11-01 2025-10-31 xbrli:pure xbrli:shares iso4217:GBP